Skechers Performance UK Releases a GOwalk
4™ Footwear Collection to support Breast Cancer Care
Skechers Performance UK Division, is thrilled to confirm their
ongoing partnership with Breast Cancer Care, to help support women
across the UK who are facing breast cancer. Skechers Performance UK
will launch a month-long marketing campaign that includes in-store,
print and social media activity. To re-launch the partnership,
Skechers Performance UK are releasing a new, limited edition GOwalk
4™ footwear collection marked with the iconic breast cancer
awareness pink ribbon, which will be available in SKECHERS retail
stores from the 7th April and online April 1st, 2017.
“We are extremely proud to announce our continued partnership
with Breast Cancer Care,” said Peter Youell, SKECHERS UK &
Ireland Managing Director. “It is an important charity that
provides significant care and support for those affected by breast
cancer. Following the success of our first campaign, we wanted to
further our support for the charity, and with this new
collaboration, we wish to continue building awareness surrounding
all the incredible work that Breast Cancer Care does. We are
pleased to play a role in supporting their incredible work
providing care, support and information to help thousands of people
to find a way to live with, through and beyond breast cancer.”
Lizzie Iredale, Head of Corporate Partnerships at Breast Cancer
Care added, “We are delighted that Skechers are continuing to
support Breast Cancer Care. The funds Skechers raise will help us
to continue to provide anyone affected by breast cancer with the
best care, support and information when they need it most.
“Every year around 62,000 people are diagnosed with Breast
Cancer in the UK, that’s around one person every ten minutes, so
there’s never been such an urgent need for our support
services.”
The Skechers Performance Breast Cancer Care collection is
available in two Skechers GOwalk 4 styles, and will retail for
£59.00. A donation of £5 per pair sold will be donated to the
charity. The designs incorporate a black, white and charcoal colour
pallet with the classic pink hue weaved in. Each style also
features the iconic pink ribbon detailing on the heel. The Skechers
GOwalk 4 shoes available in both slip-on and lace-up styles and
features the new Skechers Goga Max® insole for the most advanced
walking experience ever. The shoe also has responsive flexibility
for a more natural movement and incorporates Goga Pillars™ for
added comfort and a tapering midfoot for improved arch support.
The limited edition Skechers Performance Breast Cancer Care line
is available at SKECHERS retail stores in the United Kingdom and
online at Skechers.co.uk throughout April. The funds raised will
help Breast Cancer Care continue to provide support for anyone
affected by breast cancer.
For more information about breast cancer and the charity visit
www.breastcancercare.org.uk.
To learn more about Skechers Performance visit
www.skechers.co.uk and follow us on Facebook
(facebook.com/SkechersPerformanceUK), Twitter
(twitter.com/SKXPerformance)
ABOUT SKECHERS USA, INC.
SKECHERS USA, Inc., based in Manhattan Beach, California,
designs, develops and markets a diverse range of lifestyle footwear
for men, women and children, as well as performance footwear for
men and women. SKECHERS footwear is available in the United States
and over 160 countries and territories worldwide via department and
specialty stores, more than 2,012 SKECHERS Company-owned and
third-party-owned retail stores, and the Company’s e-commerce
websites. The Company manages its international business through a
network of global distributors, joint venture partners in Asia and
the Middle East, and wholly-owned subsidiaries in Canada, Japan,
throughout Europe and Latin America. For more information, please
visit skechers.com and follow us on Facebook
(facebook.com/SKECHERS) and Twitter (twitter.com/SKECHERSUSA).
This announcement contains forward-looking statements that are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements include, without limitation, the Company’s future
domestic and international growth, financial results and operations
including expected net sales and earnings, its development of new
products, future demand for its products, its planned domestic and
international expansion and opening of new stores, and advertising
and marketing initiatives. Forward-looking statements can be
identified by the use of forward-looking language such as
“believe,” “anticipate,” “expect,” “estimate,” “intend,” “plan,”
“project,” “will be,” “will continue,” “will result,” “could,”
“may,” “might,” or any variations of such words with similar
meanings. Any such statements are subject to risks and
uncertainties that could cause actual results to differ materially
from those projected in forward-looking statements. Factors that
might cause or contribute to such differences include international
economic, political and market conditions including the uncertainty
of sustained recovery in Europe; sustaining, managing and
forecasting costs and proper inventory levels; losing any
significant customers; decreased demand by industry retailers and
cancellation of order commitments due to the lack of popularity of
particular designs and/or categories of products; maintaining brand
image and intense competition among sellers of footwear for
consumers, especially in the highly competitive performance
footwear market; anticipating, identifying, interpreting or
forecasting changes in fashion trends, consumer demand for the
products and the various market factors described above; sales
levels during the spring, back-to-school and holiday selling
seasons; and other factors referenced or incorporated by reference
in the Company’s annual report on Form 10-K for the year ended
December 31, 2016. The risks included here are not exhaustive. The
Company operates in a very competitive and rapidly changing
environment. New risks emerge from time to time and the companies
cannot predict all such risk factors, nor can the companies assess
the impact of all such risk factors on their respective businesses
or the extent to which any factor, or combination of factors, may
cause actual results to differ materially from those contained in
any forward-looking statements. Given these risks and
uncertainties, you should not place undue reliance on
forward-looking statements as a prediction of actual results.
Moreover, reported results should not be considered an indication
of future performance.
About Breast Cancer Care
When you have breast cancer, everything changes. Time becomes
measured in appointments. The next scan. The next results. The next
challenge.
At Breast Cancer Care, we understand the emotions, challenges
and decisions you face every day. So, from the day you notice
something’s not right to the day you begin to move forward, we’ll
be here to help you through.
Whether you want to speak to our nurses, download our specialist
information or connect with volunteers who have faced what you are
facing now, we can help you feel more in control.
For care, support and information from day one, call us free on
0808 800 6000 or visit breastcancercare.org.uk
###
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170407005330/en/
SkechersNicola Zachariadesnicolaz@eu.skechers.com01707
655 955
Skechers USA (NYSE:SKX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Skechers USA (NYSE:SKX)
Historical Stock Chart
From Apr 2023 to Apr 2024